贝叶斯网络归算方法应用于多omics数据,在含有不完整数据的2型糖尿病数据集中确定假定的因果关系:IMI DIRECT研究
Richard Howey1,2, Jonathan Adam3, Jerzy Adamski4,5,6
1Research Software Engineering, Newcastle University, Newcastle upon Tyne, United Kingdom.
PLoS genetics
|July 15, 2025
概括
研究人员使用贝叶斯网络分析2型糖尿病数据,确定基因,蛋白质和临床因素之间的潜在因果关系. 这种方法证实了已知的发现,并揭示了糖尿病发展的新见解.
科学领域:
- 遗传学和生物信息学 遗传学和生物信息学
- 代谢学和蛋白质学.
- 计算生物学是一种计算生物学.
背景情况:
- 2型糖尿病 (T2D) 研究涉及复杂的,多omics数据.
- 现有的分析方法与大型,不完整的数据集作斗争.
- 贝叶斯网络为推断因果关系提供了一个强大的方法.
研究的目的:
- 展示一个新的贝叶斯网络方法用于分析复杂的T2D数据的实用性.
- 确定T2D中遗传,分子和临床变量之间的潜在因果关系.
- 验证一种新的归算方法,用于处理大型生物数据集中缺少的数据.
主要方法:
- 使用贝叶斯网络方法对大型北欧T2D数据集 (3029个人) 的探索性分析.
- 应用BayesNetty软件包,能够处理带有缺失值的混合离散/连续数据.
- 利用一种新的归算方法,从不完整的数据 (260个变量) 构建一个平均贝叶斯网络.
主要成果:
- 确认了已知的关联,并确定了与T2D相关的新型潜在调解蛋白和基因.
- 复制了之前建议的T2D和肝脏脂肪之间的因果关系.
- 证明了贝叶斯·内蒂方法及其归算技术对复杂生物数据分析的有效性.
结论:
- 开发的贝叶斯网络方法,实施在BayesNetty,是有效的发现因果关系在大型,多omicsT2D数据集.
- 该方法成功处理缺失的数据,使得比标准技术更深入的洞察力.
- 生成的网络为进一步的T2D研究提供了宝贵的资源.
相关概念视频
Causality in Epidemiology
872
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
872
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
129
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
129
Genomics
37.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.5K
Genome-wide Association Studies-GWAS
14.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.3K
Mechanistic Models: Compartment Models in Individual and Population Analysis
87
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
87
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
230
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
230


